Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments
Author:
Yu Shouzhi1, Wei Yangyang1, Liang Hongyang1, Ji Wenheng1, Chang Zhen1, Xie Siman1, Wang Yichuan1, Li Wanli1, Liu Yingwei1, Wu Hao1, Li Jie1, Wang Hui1, Yang Xiaoming2ORCID
Affiliation:
1. Beijing Institute of Biological Products Company Limited, Beijing 100176, China 2. China National Biotec Group Company Limited, Beijing 100024, China
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused huge social and economic distress. Given its rapid spread and the lack of specific treatment options, SARS-CoV-2 needs to be inactivated according to strict biosafety measures during laboratory diagnostics and vaccine development. The inactivation method for SARS-CoV-2 affects research related to the natural virus and its immune activity as an antigen in vaccines. In this study, we used size exclusion chromatography, western blotting, ELISA, an electron microscope, dynamic light scattering, circular dichroism, and surface plasmon resonance to evaluate the effects of four different chemical inactivation methods on the physical and biochemical characterization of SARS-CoV-2. Formaldehyde and β-propiolactone (BPL) treatment can completely inactivate the virus and have no significant effects on the morphology of the virus. None of the four tested inactivation methods affected the secondary structure of the virus, including the α-helix, antiparallel β-sheet, parallel β-sheet, β-turn, and random coil. However, formaldehyde and long-term BPL treatment (48 h) resulted in decreased viral S protein content and increased viral particle aggregation, respectively. The BPL treatment for 24 h can completely inactivate SARS-CoV-2 with the maximum retention of the morphology, physical properties, and the biochemical properties of the potential antigens of the virus. In summary, we have established a characterization system for the comprehensive evaluation of virus inactivation technology, which has important guiding significance for the development of vaccines against SARS-CoV-2 variants and research on natural SARS-CoV-2.
Funder
Beijing Nova Program Beijing Science and technology plan
Subject
Virology,Infectious Diseases
Reference26 articles.
1. Vaccines platforms and COVID-19: What you need to know;Trop. Dis. Travel Med. Vaccines,2022 2. Agrati, C., Carsetti, R., Bordoni, V., Sacchi, A., Quintarelli, C., Locatelli, F., Ippolito, G., and Capobianchi, M.R. (2022). The Immune Response as a Double-Edged Sword: The Lesson Learnt during the COVID-19 Pandemic. Immunology, Available online: https://onlinelibrary.wiley.com/doi/epdf/10.1111/imm.13564. 3. Sarilumab Administration in COVID-19 Patients: Literature Review and Considerations;Marino;Infect. Dis. Rep.,2022 4. High-flow nasal cannula oxygenation and tocilizumab administration in patients critically ill with COVID-19: A report of three cases and a literature review;Marino;World Acad. Sci. J.,2020 5. Loveday, E.K., Hain, K.S., Kochetkova, I., Hedges, J.F., Robison, A., Snyder, D.T., Brumfield, S.K., Young, M.J., Jutila, M.A., and Chang, C.B. (2021). Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure. Viruses, 13.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|